- Home
- FHTX vs JRVR Comparison
FHTX vs JRVR Comparison
Compare FHTX & JRVR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | FHTX | JRVR |
|---|---|---|
| Founded | 2015 | 2002 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medicinal Chemicals and Botanical Products | Property-Casualty Insurers |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 323.4M | 288.2M |
| IPO Year | 2020 | 2014 |
Fundamental Metrics
Financial Performance| Metric | FHTX | JRVR |
|---|---|---|
| Price | $4.26 | $4.38 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 8 | 3 |
| Target Price | ★ $11.50 | $7.33 |
| AVG Volume (30 Days) | 106.1K | ★ 296.3K |
| Earning Date | 05-06-2026 | 05-04-2026 |
| Dividend Yield | N/A | ★ 0.64% |
| EPS Growth | 25.32 | ★ 125.82 |
| EPS | N/A | ★ N/A |
| Revenue | $30,909,000.00 | ★ $687,614,000.00 |
| Revenue This Year | $8.89 | N/A |
| Revenue Next Year | $20.13 | $1.61 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | ★ 36.75 | N/A |
| 52 Week Low | $3.27 | $4.42 |
| 52 Week High | $6.95 | $7.20 |
Technical Indicators
Market Signals| Indicator | FHTX | JRVR |
|---|---|---|
| Relative Strength Index (RSI) | 32.46 | 14.62 |
| Support Level | $3.65 | N/A |
| Resistance Level | $5.82 | $5.66 |
| Average True Range (ATR) | 0.29 | 0.22 |
| MACD | -0.07 | -0.21 |
| Stochastic Oscillator | 10.00 | 1.15 |
Price Performance
Historical ComparisonAbout FHTX Foghorn Therapeutics Inc.
Foghorn Therapeutics Inc is a clinical stage, precision therapeutics biotechnology company focused on pioneering a new class of medicines that treat serious diseases by correcting abnormal gene expression through selectively targeting the chromatin regulatory system. Its proprietary platform is designed to provide an integrated, mechanistic understanding of interactions within the chromatin regulatory system, supporting the identification and validation of potential therapeutic targets. The company's flagship program is FHD-909.
About JRVR James River Group Holdings Ltd.
James River Group Holdings Inc is a holding company that owns and operates a group of specialty insurance companies focused on underwriting small and middle market casualty risks within the U.S. excess and surplus (E&S) lines market. The Company operates in two specialty property-casualty insurance segments: Excess and Surplus Lines and Specialty Admitted Insurance.